---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-013999"
form_type: "8-K"
ticker: "SWKHL"
cik: "0001089907"
company_name: "SWK Holdings Corp"
filed_at: "2025-03-20T23:59:59+00:00"
generated_at: "2026-05-24T09:42:35.357752+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SWK Holdings monetizes royalty portfolio for $51.3M; plans dividend

## Summary
- ANI Pharmaceuticals exercised buyout of Iluvien royalty for ~$17.3M.
- Definitive agreement with Soleus Capital to sell remaining performing royalties for ~$34.0M.
- Total $51.3M represents ~$1.0M gain over book value of $50.3M as of Dec 31, 2024.
- Soleus transaction expected to close in ~2 weeks; dividend to be declared at closing.

## SEC filing metadata
- accession: 0001628280-25-013999
- form_type: 8-K
- ticker: SWKHL
- cik: 0001089907
- company_name: SWK Holdings Corp
- filed_at: 2025-03-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1089907/000162828025013999/0001628280-25-013999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1089907/000162828025013999/swkh-20250320.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-013999
- JSON: https://secwatch.observer/filing/0001628280-25-013999.json
- Plain text: https://secwatch.observer/filing/0001628280-25-013999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.